Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05169268

Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

Sponsor: The University of Hong Kong

View on ClinicalTrials.gov

Summary

MainRexult study aims to carefully evaluate a cohort of patients with schizophrenia and related disorder prescribed with the combination therapy with Abilify Maintena and Rexulti on its efficacy and tolerability in a real-life clinical setting.

Official title: Real-life Assessment of Aripiprazole Long-acting Injection (Abilify Maintena) Combined With Brexpiprazole (Rexulti) in Schizophrenia: a Naturalistic Non-interventional Prospective Follow-up Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

10

Start Date

2022-02-01

Completion Date

2026-01-31

Last Updated

2025-07-09

Healthy Volunteers

Not specified

Interventions

DRUG

ARIPiprazole Injection [Abilify]

subject already receiving the combination of Abilify Maintena and Rexulti

DRUG

Brexpiprazole

subject already receiving the combination of Abilify Maintena and Rexulti

Locations (1)

Queen Mary Hospital

Hong Kong, Hong Kong